Nephrotect otopina za infuziju
| Name | Nephrotect otopina za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-058269986 |
| Active Substance | izoleucin leucin lizinacetat metionin fenilalanin treonin triptofan valin arginin histidin alanin acetilcistein glicin prolin serin tirozin glicil-tirozin |
| Composition | 1000 ml otopine za infuziju sadrži: 5,80 g izoleucina, 12,80 g leucina, 16,90 g lizin acetata (12,0 g lizina), 2,00 g metionina, 3,50 g fenilalanina, 8,20 g treonina, 3,00 g triptofana, 8,70 g valina, 8,20 g arginina, 9,80 g histidina, 6,20 g alanina, 0,54 g acetil cisteina (0,40 g cisteina), 5,31 g glicina, 3,00 g prolina, 7,60 g serina, 0,60 g tirozina i 3,16 g glicin-tirozina (0,994 g glicina i 2,40 g tirozina); ukupno 100 g/l aminokiselina, odnosno 16,3 g/l dušika |
| Pharmaceutical Form | otopina za infuziju |
| Manufacturer | Fresenius Kabi Austria GmbH, Graz, Austrija |
| Marketing Authorisation Holder | Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska |
| Marketing Authorisation Date | 28.07.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/717 |
| Registration Number | 381-12-01/154-20-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B05BA01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
